CLU and Alzheimer disease: Simultaneous detection of the possible AD biomarkers in blood such as complement factor H, α-2-macroglobuline, apolipoprotein E, pancreatic polypeptide, and clusterin would be necessary on a multiplexed electrochemical immunosensor platform.